Sivia Capital Partners »

Regeneron Pharmaceuticals shares owned by Sivia Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Sivia Capital Partners from 13F filings

Historical chart of Sivia Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Sivia Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Sivia Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $261k 271 962.49
2023-12-31 $238k 271 878.29

More positions owned by Sivia Capital Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Snowflake Cl A (SNOW)
Apple (AAPL)
Amazon (AMZN)
Dimensional Etf Trust World Equity Etf (DFAW)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Sivia Capital Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals